Attenuation of Endotoxin-Induced Cytotoxicity and Prostacyclin Production in Cultured Bovine Pulmonary Artery Endothelial Cells by Phosphodiesterase Inhibition
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 14 (5) , 637-654
- https://doi.org/10.3109/01902148809087834
Abstract
Exposure of cultured bovine pulmonary endothelial cells to endotoxin (lipopoly-saccharide, LPS) causes cytotoxicity and increased prostacyclin production. Since cyclic nucleotides have been proposed as modulators of inflammation, we wondered whether they were involved in LPS-induced endothelial damage. Bovine pulmonary endothelial cells were exposed for 24 h to LPS and the effects of l-methyl-3-isobutylxanthine (MIX), a phosphodiesterase inhibitor, dibutyryl cyclic AMP (db-cAMP), forskolin (an adenylate cyclase activator), and sodium nitroprusside (an agent known to stimulate intracellular cyclic GMP generation) on LPS-induced injury were determined. Injury was assessed by measurement of lactate dehydrogenase (LDH) (activity) and prostacyclin (6-keto-PGF,J in the bathing medium. Incubation with MIX attenuated LPS-induced endothelial cytotoxicity and prostacyclin production in a dose-dependent manner (ANOVA, p < 0.001). Dibutyryl cyclic AMP also inhibited LPS-stimulated LDH release from the endothelial cells but did not suppress increased prostacyclin production. The combinations of MIX and dibutyryl cyclic AMP produced protection similar to that of MIX alone. Neither nitroprusside nor forskolin affected LPS-induced endothelial injury. Measurements of intracellular cyclic nucleotide concentrations showed that MIX caused marked increases in both cyclic AMP and cyclic GMP within 30 min of incubation, while forskolin and nitroprusside failed to cause such early elevations. Thus, phosphodiesterase inhibition protects endothelial cells from the effects of LPS. Increased intracellular concentrations of cyclic AMP also protect endothelial cells from LPS-induced cytotoxicity but do not alter the prostanoid response. We conclude that increased intracellular concentrations of cyclic AMP protect against LPS-induced endothelial cytotoxicity if present early in the exposure. We further conclude that LPS-mediated endothelial cytotoxicity can be separated from increased prostacyclin production.This publication has 34 references indexed in Scilit:
- Induction of prostacyclin biosynthesis is closely associated with increased guanosine 3',5'-cyclic monophosphate accumulation in cultured human endothelium.Journal of Clinical Investigation, 1986
- Isolation and culture of pulmonary endothelial cells.Environmental Health Perspectives, 1984
- Inhibition of prostacyclin synthesis in endothelial cells by methylisobutylxanthine is not mediated through elevated cAMP levelBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.Journal of Clinical Investigation, 1981
- Prostacyclin Reversal of Lethal Endotoxemia in DogsJournal of Clinical Investigation, 1981
- Thromboxane B2: A cardiodepressant of isolated rat hearts and inhibitor of sarcolemma Na+ — K+ stimulated atpase activityProstaglandins and Medicine, 1979
- Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgGClinical Immunology and Immunopathology, 1978
- A SEQUENCE OF BIOCHEMICAL EVENTS IN THE ANTIGEN-INDUCED RELEASE OF CHEMICAL MEDIATORS FROM SENSITIZED HUMAN LUNG TISSUEThe Journal of Experimental Medicine, 1973
- Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1973
- THE MODULATING INFLUENCE OF CYCLIC NUCLEOTIDES UPON LYMPHOCYTE-MEDIATED CYTOTOXICITYThe Journal of Experimental Medicine, 1973